Peelay, Z., Mehrotra, K., Bhattacharjee, A., Menon, N. S., Jadhav, S. B., Kazi, B., Vairamoorthy, N., Karpe, A. P., Patil, V. M. (2026). CLARITY-GBM: A phase II, multi-centered, open-label, single-arm study to evaluate the safety and efficacy of cetuximab and lomustine (CCNU) in adult patients with recurrent high-grade glioblastoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2095